Autologous cultured chondrocytes - Sewon CellontechAlternative Names: Autologous chondrocyte implantation; CHONDRON; Gel-ACI; Gel-type autologous chondrocyte implantation
Latest Information Update: 03 Sep 2015
At a glance
- Originator Sewon Cellontech Company Limited
- Class Cell therapies
- Mechanism of Action Cartilage replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Cartilage disorders; Knee injuries; Osteonecrosis